Mark Ehlert

Senior Vice President of Scientific Affairs

As senior vice president of scientific affairs for Devicor^® Medical Products, Inc., Mark Ehlert brings 32 years of experience in the medical device and drug industries. After “retiring” in 2007, Ehlert served as president of 315 Ventures, Ltd., a small company devoted to bioscience and medical device startup companies, and due diligence activities associated with mergers and acquisitions.

Ehlert started his career in 1975 with Baxter Healthcare and continued there for more than 20 years, until he joined Allegiance Healthcare. During his time at Baxter, he worked in manufacturing operations for IV fluids, injectable drugs, simple medical devices and electronic infusion devices, and spent time expanding Baxter’s presence in Asia.

At Allegiance, Ehlert was responsible for quality, regulatory affairs, EH&S and research & development functions. Later, he served as a member of the senior management team that helped Abbott Laboratories create Hospira, Inc., as the corporate vice president of quality and regulatory affairs.